Events

Videos

Podcasts

Articles

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Stem Cell Transplantation in Follicular Lymphoma

Frontline Treatments for Follicular Lymphoma

Ibrutinib in WaldenstrÃ¶m's Macroglobulinemia

B-Cell Receptor Inhibitor Response Criteria in CLL

Emerging Strategies in CLL and Follicular Lymphoma 

Ibrutinib-Associated Adverse Events

Ibrutinib Monotherapy and Combinations in CLL

Preventing Infusion Reactions With CD20 Antibodies in CLL

Role of B-Cell Receptor Signaling Inhibitors in CLL

Changing Treatment Landscape in CLL

Future Immunotherapies for Hematologic Malignancies

PD-1 Inhibition in Hodgkin's Lymphoma

Treatment Advancements in Lymphoma

Daratumumab, Vaccines in Multiple Myeloma

Elotuzumab in Relapsed/Refractory Multiple Myeloma

Measuring Response to Novel Therapies in ALL

Blinatumomab in Philadelphia Chromosome-Negative ALL

Rituximab, Obinutuzumab, and Ofatumumab in CLL

Immunotherapy-Related Adverse Events

Responses With Immunotherapy Versus Chemotherapy

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 